NCT02814435

Brief Summary

Inherited retinal degeneration (IRD) is a major cause of blindness and partial loss of vision cases in the UK and starts at an early age. The purpose of this observational study is to use the results of two questionnaires and a computerised test testing contrast sensitivity, to assess the impact of IRD on quality of life. This study will involve collecting data from patients with IRD, but also collecting data from normal controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 27, 2016

Completed
4 days until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

November 13, 2018

Status Verified

November 1, 2018

Enrollment Period

1.3 years

First QC Date

June 23, 2016

Last Update Submit

November 8, 2018

Conditions

Keywords

RetinaRetinal DegenerationQuality of Life Measures

Outcome Measures

Primary Outcomes (1)

  • Impact of inherited retinal degeneration on quality of life measures.

    This will be assessed by comparing questionnaire results between different inherited retinal degeneration types.This will be determined by using ANOVA testing to compare scores caused by different genetic mutations, allowing us to relate mutations causing central versus peripheral visual loss to the quality of life measures.

    May 2016 to May 2017

Secondary Outcomes (1)

  • Effect of contrast sensitivity function on quality of life.

    May 2016 to May 2017

Study Arms (2)

Patients

Patients with inherited retinal degeneration will answer two questionnaires and undergo a computerised contrast sensitivity function test.

Other: QuestionnaireOther: Computerised contrast sensitivity function test

Normal controls

Normal controls recruited by advertising will answer two questionnaires and undergo a computerised test that assess contrast sensitivity function.

Other: QuestionnaireOther: Computerised contrast sensitivity function test

Interventions

The participants will answer two questionnaires. These are the NEI VFQ-25 and the DLTV (daily living tasks of vision).

Normal controlsPatients

This test involves the patient identifying whether bars on a screen are horizontal or vertical. It is designed to measure contrast sensitivity.

Normal controlsPatients

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

60 patients with inherited retinal degeneration will be recruited from the outpatient clinic in the Oxford Eye Hospital. 30 healthy controls will be recruited from advertising around the OUH hospitals and the University of Oxford.

You may qualify if:

  • Participant is willing \& able to give informed consent for participation in the study.
  • Male or female, aged 18 - 85.
  • A clinical or genetic diagnosis of retinal degeneration or normal age and sex-matched controls without known retinal disease.
  • Able to participate in visual function testing.

You may not qualify if:

  • The participant may not enter the study if any of the following apply:
  • \) they have a pre-existing amblyopia or squint;
  • \) they have any other retinal problems that may confound the measures assessed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oxford Eye Hospital

Oxford, OX3 9DU, United Kingdom

Location

Related Links

MeSH Terms

Conditions

Retinal Degeneration

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Eye Diseases, HereditaryEye DiseasesRetinal Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Jasleen K Jolly, MSc

    University of Oxford

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2016

First Posted

June 27, 2016

Study Start

July 1, 2016

Primary Completion

October 1, 2017

Study Completion

October 1, 2017

Last Updated

November 13, 2018

Record last verified: 2018-11

Locations